<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">R</forename><surname>Leistner</surname></persName>
							<email>rasmus.leistner@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Bloch</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Medical and Financial Controlling</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Schwab</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">16BFCE9F4B35365C84415BC0BAD70CB6</idno>
					<idno type="DOI">10.1186/s13756-016-0138-z</idno>
					<note type="submission">Received: 30 May 2016 Accepted: 3 October 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>ESBL</term>
					<term>Bacteremia</term>
					<term>Sepsis</term>
					<term>K. pneumoniae</term>
					<term>E. coli</term>
					<term>Enterobacteriaceae</term>
					<term>Mortality</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>In a previous study, we demonstrated prolonged length of hospital stay in cases of extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae bacteremia compared to bacteremia cases due to E. coli (ESBL-positive and -negative) and ESBL-negative K. pneumoniae.</s><s>The overall mortality was significantly higher in bacteremia cases resulting from ESBL-positive pathogens but also in K. pneumoniae cases disregarding ESBL-production.</s><s>In order to examine whether pathogen species rather than multidrug resistance might affect mortality risk, we reanalyzed our dataset that includes 1.851 cases of bacteremia.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>The incidence of infections associated with multidrugresistant Gram-negative organisms like extendedspectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) is growing in Germany <ref type="bibr" target="#b0">[1]</ref>.</s><s>These infections, according to reports, result in increased mortality and an elevated financial burden for hospitals and health care systems <ref type="bibr" target="#b1">[2]</ref>.</s><s>In 2014, we published the results of a study on the costs of bloodstream infections (BSI) with ESBL-E and length of resulting hospital stays <ref type="bibr" target="#b2">[3]</ref>.</s><s>Our data showed that in particular K. pneumoniae was related to prolonged length of stays and increased hospital costs regardless the detection of ESBL production.</s><s>We furthermore observed a significantly increased overall mortality associated with ESBL-positive pathogens (25.0 % vs. 19.0</s><s>%, p-value = 0.028).</s><s>However, this difference in mortality was also observed in K. pneumoniae cases compared to E. coli cases without considering ESBL-production (25.0 % vs. 18.5 %, p = 0.006).</s><s>This observation posed the question whether the pathogen species or multidrug resistance had a greater influence on the mortality rate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>We reanalyzed the dataset to examine risk factors for mortality including pathogen species and ESBL production.</s><s>All definitions remained the same from the previous publication with the exception of mortality rate.</s><s>In order to detect mortality rates attributable to the bloodstream infection (BSI-attributable mortality), we focused on the 7-day mortality rate after BSI onset.</s><s>All other definitions were following the original publication.</s><s>The median and the interquartile range (IQR) were calculated for continuous parameters, numbers and percentage were calculated for binary parameters.</s><s>Differences between deceased patients and those who survived were tested using the Wilcoxon rank sum test for continuous variables and the Chi square test for binary variables.</s><s>A p-value &lt;0.05 was considered statistically significant.</s><s>In the multivariable analysis, Coxproportional hazard regression analysis was performed to investigate the risk factors for mortality ≤7 days after BSI onset (BSI-attributable mortality).</s><s>We calculated adjusted hazard ratios (HR) for pathogen species and ESBLpositivity.</s><s>Model building strategy was step-wise forward with a p-value &lt; .05</s><s>for including a variable in the model.</s><s>All parameters with a p-value &lt;0.1 in the univariable analysis were considered in the multivariable analysis, and the interaction between pathogen species and ESBL-positivity were included in all multivariable models.</s><s>Underlying comorbidities were assessed as in the original publication.</s><s>In order to enable a comparison between the risk factors for BSI-attributable mortality (7-day mortality) and in-hospital mortality, the analysis was repeated for the latter using the same parameters and statistical method.</s><s>All analyses were performed using SPSS (IBM SPSS statistics, Somer, NY, USA) and SAS (SAS Institute, Cary, NC, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Overall 8.7 % (n = 161) of the patients were deceased within seven days of developing a bloodstream infection whereas n = 205 (11.1 %) patients died at a later point in time during their hospital stay (Table <ref type="table" target="#tab_0">1</ref>).</s><s>In the univariable analysis, patients who died within the 7 days after BSI onset were significantly older compared to the 7-day survivors.</s><s>However, this was not observed concerning overall in-hospital mortality.</s><s>With respect to the 7-day mortality, there was no statistical significant difference observed concerning ESBL-production or pathogen species.</s><s>Furthermore, the following parameter showed significantly increased risk for overall in-hospital mortality but not for 7-day mortality: polymicrobial BSI, male sex, hospital onset, cerebrovascular disease, lung disease and cancer/immunological disease.</s></p><p><s>In the multivariable analysis, independently associated factors with 7-day mortality were renal disease, liver disease, cancer /immunological disease and heart disease (Table <ref type="table" target="#tab_1">2</ref>).</s><s>No effect was observed concerning neither pathogen species nor ESBL-production.</s><s>For overall in-hospital mortality, a similar risk profile could be observed concerning underlying diseases.</s><s>Here, BSI with ESBL-negative K. pneumoniae was found to be an independent risk factor for overall inhospital mortality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In earlier studies, ESBL-positive pathogens causing infections were associated with increased mortality <ref type="bibr" target="#b1">[2]</ref>.</s><s>However, recent studies have cast doubt on this general assumption and showed a lack of sufficiently controlled studies especially with respect to antimicrobial treatment <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>Unfortunately, we do not have sufficient data on antimicrobial treatment and are unable to examine this assumption.</s><s>Especially carbapenem resistance poses a serious threat, as carbapenems are the most important reserve substances for these infections <ref type="bibr" target="#b5">[6]</ref>.</s><s>However, our cohort was comprised of only two cases resulting from carbapenem-resistant organisms.</s></p><p><s>In the original publication, K. pneumoniae cases were associated with a significantly higher comorbidity index (6 vs. 5, p = 0.001).</s><s>K. pneumoniae BSIs were more often associated with the detection of other organisms in the same blood culture (24.4 % vs. 9.9 %, p ≤ 0.001) and they occurred later than the respective E. coli BSIs (hospital day 6 vs. 1, p ≤ 0.001).</s><s>These observations indicate epidemiological and pathophysiological differences between both groups that we do not yet entirely understand.</s></p><p><s>In the analysis at hand, we observed severe comorbidities, like renal disease, liver disease or cancer to be the only independently associated risk factors for BSIattributable mortality.</s><s>In contrast, ESBL-negative K. pneumoniae (in addition to comorbidities) was independently associated with in-hospital mortality.</s><s>We see this as the result of an unmeasured confounder that is associated with increased risk of mortality in the aftermath of survival from a K. pneumoniae BSI.</s></p><p><s>This analysis has limitations.</s><s>Our data lacks information on antimicrobial therapy, which could provide further information.</s><s>However, the patients were treated following current sepsis guidelines.</s><s>The guidelines do not differentiate between K. pneumoniae and E. coli and therefore render a systematical therapeutic difference unlikely.</s><s>Data on source of BSI and on the severity of disease (e.g.</s><s>sepsis, septic shock) were not sufficiently available.</s><s>Therefore, we could not adjust for the effect of these potential confounders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>ESBL-E BSI-attributable mortality was influenced neither by pathogen species nor by ESBL-production.</s><s>However, we observed epidemiological differences between patients infected with K. pneumoniae or E.coli that lead to an increased in-hospital mortality, not attributable to the BSI episode.</s><s>Both pathogens are the most commonly found representatives of ESBL-producing bacteria in clinical isolates.</s><s>Hence, it is of paramount importance to understand the factors that determine the course of infection and the overall outcome.</s><s>Thus, further well-designed studies of epidemiological and pathophysiological differences between K. pneumoniae and E. coli -infections are necessary.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Univariate analysis of 7 days mortality in patients with extended-spectrum beta-lactamase (ESBL)-positive or -negative E. coli and K. pneumoniae bloodstream infection (during hospitalization)</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>Survived until</cell><cell>Died within</cell><cell>7-days</cell><cell cols="2">P-value Survived/ discharged</cell><cell>Died in-hospital</cell><cell>In-hospital</cell><cell>P-value</cell></row><row><cell></cell><cell>7 days after BSI</cell><cell>7 days after BSI</cell><cell>Mortality</cell><cell></cell><cell>after BSI</cell><cell>after BSI</cell><cell>Mortality</cell><cell></cell></row><row><cell></cell><cell>Number (%)</cell><cell>Number (%)</cell><cell></cell><cell></cell><cell>Number (%)</cell><cell>Number (%)</cell><cell></cell><cell></cell></row><row><cell>Patients</cell><cell cols="2">1.690 (100 %) 161 (100 %)</cell><cell>8.7 %</cell><cell></cell><cell>1485 (100 %)</cell><cell>366 (100 %)</cell><cell>19.8 %</cell><cell></cell></row><row><cell>K. pneumoniae</cell><cell>319 (18.9 %)</cell><cell>33 (20.5 %)</cell><cell>9.4 %</cell><cell>0.616</cell><cell>264 (17.8 %)</cell><cell>88 (24.0 %)</cell><cell>25.0 %</cell><cell>0.006</cell></row><row><cell>E. coli</cell><cell>1371 (81.1 %)</cell><cell>128 (79.5 %)</cell><cell>8.5 %</cell><cell></cell><cell>1221 (82.2 %)</cell><cell>278 (76.0 %)</cell><cell>18.5 %</cell><cell></cell></row><row><cell>ESBL-positive</cell><cell>219 (13.0 %)</cell><cell>25 (15.5 %)</cell><cell>10.2 %</cell><cell>0.357</cell><cell>183 (12.3 %)</cell><cell>61 (16.7 %)</cell><cell>25.0 %</cell><cell>0.028</cell></row><row><cell>Hospital mortality</cell><cell>205 (12.1 %)</cell><cell>161 (100.0 %)</cell><cell cols="3">44.0 % &lt;0.001 -</cell><cell>366 (100.0 %)</cell><cell>100.0 %</cell><cell>n.a.</cell></row><row><cell>Polymicrobial</cell><cell>198 (11.7 %)</cell><cell>27 (16.8 %)</cell><cell>12.0 %</cell><cell>0.061*</cell><cell>160 (10.8 %)</cell><cell>65 (17.8 %)</cell><cell>28.9 %</cell><cell>&lt;0.001*</cell></row><row><cell>Age (years) a</cell><cell>65 (52-73) a</cell><cell>67 (57-76) a</cell><cell>n.a.</cell><cell>0.019*</cell><cell>65 (52-73) a</cell><cell>66 (54-74) a</cell><cell>n.a.</cell><cell>0.134*</cell></row><row><cell>Male</cell><cell>929 (55.0 %)</cell><cell>93 (57.8 %)</cell><cell>9.1 %</cell><cell>0.496</cell><cell>799 (53.8 %)</cell><cell>223 (60.9 %)</cell><cell>21.8 %</cell><cell>0.014</cell></row><row><cell>Hospital onset</cell><cell>746 (44.1 %)</cell><cell>84 (52.2 %)</cell><cell>10.1 %</cell><cell>0.050*</cell><cell>612 (41.2 %)</cell><cell>218 (59.6 %)</cell><cell>26.3 %</cell><cell>&lt;0.001*</cell></row><row><cell>ICU stay</cell><cell cols="2">1.072 (63.4 %) 125 (77.6 %)</cell><cell>10.4 %</cell><cell cols="2">&lt;0.001* 896 (60.3 %)</cell><cell>301 (82.2 %)</cell><cell>25.1 %</cell><cell>&lt;0.001*</cell></row><row><cell>Charlson comorbidity index a</cell><cell>5 (3-8) a</cell><cell>8 (6-10) a</cell><cell>n.a.</cell><cell cols="2">&lt;0.001 5 (3-8) a</cell><cell>8 (6-10) a</cell><cell>n.a.</cell><cell>&lt;0.001</cell></row><row><cell>Heart disease</cell><cell>275 (16.3 %)</cell><cell>47 (29.2 %)</cell><cell>14.6 %</cell><cell cols="2">&lt;0.001* 215 (14.5 %)</cell><cell>107 (29.2 %)</cell><cell>33.2 %</cell><cell>&lt;0.001*</cell></row><row><cell>Cerebrovascular disease</cell><cell>243 (14.4 %)</cell><cell>31 (19.3 %)</cell><cell>11.3 %</cell><cell>0.096*</cell><cell>202 (13.6 %)</cell><cell>72 (19.7 %)</cell><cell>26.3 %</cell><cell>0.003*</cell></row><row><cell>Neurologic disease</cell><cell>123 (7.3 %)</cell><cell>11 (6.8 %)</cell><cell>8.2 %</cell><cell>0.835</cell><cell>112 (7.5 %)</cell><cell>22 (6.0 %)</cell><cell>16.4 %</cell><cell>0.311</cell></row><row><cell>Lung disease</cell><cell>218 (12.9 %)</cell><cell>24 (14.9 %)</cell><cell>9.9 %</cell><cell>0.470</cell><cell>181 (12.2 %)</cell><cell>61 (16.7 %)</cell><cell>25.2 %</cell><cell>0.023</cell></row><row><cell>Gastrointestinal disease</cell><cell>53 (3.1 %)</cell><cell>12 (7.5 %)</cell><cell>18.5 %</cell><cell cols="2">0.004* 36 (2.4 %)</cell><cell>29 (7.9 %)</cell><cell>44.6 %</cell><cell>&lt;0.001*</cell></row><row><cell>Rheumatic disease</cell><cell>50 (3.0 %)</cell><cell>2 (1.2 %)</cell><cell>3.8 %</cell><cell>0.208</cell><cell>44 (3.0 %)</cell><cell>8 (2.2 %)</cell><cell>15.4 %</cell><cell>0.420</cell></row><row><cell>Liver disease</cell><cell>258 (15.3 %)</cell><cell>53 (32.9 %)</cell><cell>17.0 %</cell><cell cols="2">&lt;0.001* 180 (12.1 %)</cell><cell>131 (35.8 %)</cell><cell>42.1 %</cell><cell>&lt;0.001*</cell></row><row><cell>Diabetes</cell><cell>422 (25.0 %)</cell><cell>48 (29.8 %)</cell><cell>10.2 %</cell><cell>0.177</cell><cell>366 (24.6 %)</cell><cell>104 (28.4 %)</cell><cell>22.1 %</cell><cell>0.138</cell></row><row><cell>Renal disease</cell><cell>711 (42.1 %)</cell><cell>115 (71.4 %)</cell><cell>13.9 %</cell><cell cols="2">&lt;0.001* 565 (38.0 %)</cell><cell>261 (71.3 %)</cell><cell>31.6 %</cell><cell>&lt;0.001*</cell></row><row><cell cols="2">Cancer/immunological disease 672 (39.8 %)</cell><cell>75 (46.6 %)</cell><cell>10.0 %</cell><cell>0.092*</cell><cell>571 (38.5 %)</cell><cell>176 (48.1 %)</cell><cell>23.6 %</cell><cell>0.001*</cell></row></table><note><p><s>BSI bloodstream infection, LOS length of stay, N.a.</s><s>not applicable * Included in the multivariable Cox-proportional hazard regression a Continuous parameter displayed as median (interquartile range) P-values &lt;0.05 were considered statistically significant</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Multivariable Cox-proportional hazard regression of risk factors for 7-day mortality and hospital mortality after BSI with ESBL-positive or -negative E. coli and K. pneumoniae ESBL extended-spectrum beta-lactamase, HR hazard ratio, CI95 95 % confidence interval, N.s.</s><s>not significant a Analyzing the same parameters as in 7-days mortality P-values &lt;0.05 were considered statistically significant</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>Parameter/ category</cell><cell cols="2">7-days mortality (stepwise)</cell><cell></cell><cell cols="2">In-hospital mortality a</cell><cell></cell></row><row><cell></cell><cell></cell><cell>HR</cell><cell>CI95</cell><cell cols="2">P-value HR</cell><cell>CI95</cell><cell>P-value</cell></row><row><cell>Interaction effect between pathogen</cell><cell>E. coli ESBL-negative</cell><cell>1 = Reference</cell><cell></cell><cell>0.947</cell><cell>1 = Reference</cell><cell></cell><cell>0.084</cell></row><row><cell>species and ESBL-production</cell><cell>E. coli ESBL-positive</cell><cell>1.16</cell><cell>0.70-1.90</cell><cell>0.571</cell><cell>1.22</cell><cell>0.88-1.68</cell><cell>0.228</cell></row><row><cell></cell><cell>K. pneumoniae ESBL-negative</cell><cell>0.98</cell><cell>0.64-1.50</cell><cell>0.926</cell><cell>1.39</cell><cell cols="2">1.07-1.82 0.015</cell></row><row><cell></cell><cell>K. pneumoniae ESBL-positive</cell><cell>1.05</cell><cell>0.49-2.27</cell><cell>0.894</cell><cell>1.01</cell><cell>0.60-1.67</cell><cell>0.983</cell></row><row><cell>Comorbidities</cell><cell>Heart disease</cell><cell>1.55</cell><cell cols="2">1.09-2.21 0.014</cell><cell>1.23</cell><cell>0.97-1.56</cell><cell>0.087</cell></row><row><cell></cell><cell>Liver disease</cell><cell>1.96</cell><cell cols="3">1.40-2.74 &lt;0.001 1.85</cell><cell cols="2">1.48-2.30 &lt;0.001</cell></row><row><cell></cell><cell>Renal disease</cell><cell>2.86</cell><cell cols="3">1.99-4.10 &lt;0.001 2.32</cell><cell cols="2">1.82-2.95 &lt;0.001</cell></row><row><cell></cell><cell cols="2">Cancer/ immunological disease 1.66</cell><cell cols="2">1.21-2.28 0.002</cell><cell>1.58</cell><cell cols="2">1.28-1.95 &lt;0.001</cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>The complete anonymized dataset is available from the corresponding author upon request.</s></p><p><s>Authors' contributions PG and RL developed the idea, RL and FS drafted the manuscript.</s><s>FS developed the mathematical model and performed the statistical analysis.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>The approval of the ethics committee of Charité Universitätsmedizin Berlin for this study was obtained previously (process number EA4/031/11).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Leistner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geffers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Breier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Behnke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="255" to="e256" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Shorr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1463" to="1469" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort</title>
		<author>
			<persName><forename type="first">R</forename><surname>Leistner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gurntke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sakellariou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Denkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="991" to="997" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Effects of confounders and intermediates on the association of bacteraemia caused by extendedspectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Rottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Ammerlaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bonten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1311" to="1320" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schwaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Carmeli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="913" to="920" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Antimicrobial resistance</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Marston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Knisely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Palmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Fauci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">316</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1193" to="1204" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
